Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : PYNG Technologies -- Ignore unavailable to you. Want to Upgrade?

To: m. jacobs who wrote (4571)	9/13/1999 6:40:00 PM
From: HotShot1	Read Replies (4) \| Respond to of 8117

I know I'm a pessimist, but what does the following mean to you? "The agreement calls for Biomedix Corp. to distribute a minimum 12,600 units of the F.A.S.T.1 System over a 24-month period in the Canadian marketplace." That's 6,300 minimum per year, or $63,000 in revenue per year. The goals aren't what people expected. They're more in line with what I have been predicting - a nickel and dime business for the first few years. Mind you, I guess there will be equal or better business coming in from the States. So maybe we'll see $150,000 to $200,000 in revenue for next year. It's small, but I guess it's a start. Personally, I think the stock is being taken up superficially in order to allow for a private placement at a higher price. A company should not be valued at over $20 million ($1.70/share) if they're only going to do one tenth of that in revenue, and maybe 5% in net profit. So why the high stock price, less dilution from a future placement? I think so. I'm not going to buy at this level. I'm a patient man. When the disappointing order #'s reveal themselves over the next 12 months, I'll start to accumulate between $1.25 and $1.50, which I think is too high, but this market is screwy, and in turn, I can't see it falling below a $1.25. Good luck to all.